Susceptibility genes of hyperuricemia and gout
- PMID: 35922835
- PMCID: PMC9351246
- DOI: 10.1186/s41065-022-00243-y
Susceptibility genes of hyperuricemia and gout
Abstract
Gout is a chronic metabolic disease that seriously affects human health. It is also a major challenge facing the world, which has brought a heavy burden to patients and society. Hyperuricemia (HUA) is the most important risk factor for gout. In recent years, with the improvement of living standards and the change of dietary habits, the incidence of gout in the world has increased dramatically, and gradually tends to be younger. An increasing number of studies have shown that gene mutations may play an important role in the development of HUA and gout. Therefore, we reviewed the existing literature and summarized the susceptibility genes and research status of HUA and gout, in order to provide reference for the early diagnosis, individualized treatment and the development of new targeted drugs of HUA and gout.
Keywords: Gout; Hyperuricemia; Serum uric acid; Single nucleotide polymorphism; Susceptibility gene.
© 2022. The Author(s).
Conflict of interest statement
There is no conflict of interest between all authors.
Figures


Similar articles
-
Common variants in the SLC28A2 gene are associated with serum uric acid level and hyperuricemia and gout in Han Chinese.Hereditas. 2019 Jan 16;156:4. doi: 10.1186/s41065-018-0078-0. eCollection 2019. Hereditas. 2019. PMID: 30679935 Free PMC article.
-
[Epidemiological study on hyperuricemia and gout in Foshan areas, Guangdong province].Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Aug;31(8):860-2. Zhonghua Liu Xing Bing Xue Za Zhi. 2010. PMID: 21162982 Chinese.
-
Genetic factors associated with gout and hyperuricemia.Adv Chronic Kidney Dis. 2006 Apr;13(2):124-30. doi: 10.1053/j.ackd.2006.01.008. Adv Chronic Kidney Dis. 2006. PMID: 16580613 Review.
-
Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.Int J Mol Sci. 2021 Feb 16;22(4):1935. doi: 10.3390/ijms22041935. Int J Mol Sci. 2021. PMID: 33669292 Free PMC article.
-
ABCG2 as a therapeutic target candidate for gout.Expert Opin Ther Targets. 2018 Feb;22(2):123-129. doi: 10.1080/14728222.2018.1420167. Epub 2017 Dec 28. Expert Opin Ther Targets. 2018. PMID: 29264928 Review.
Cited by
-
Gout and Hyperuricemia: A Narrative Review of Their Comorbidities and Clinical Implications.J Clin Med. 2024 Dec 13;13(24):7616. doi: 10.3390/jcm13247616. J Clin Med. 2024. PMID: 39768539 Free PMC article. Review.
-
Molecular basis of the urate transporter URAT1 inhibition by gout drugs.Nat Commun. 2025 Jun 4;16(1):5178. doi: 10.1038/s41467-025-60480-3. Nat Commun. 2025. PMID: 40467597 Free PMC article.
-
Novel Potential Probiotics from Chinese Baijiu Fermentation Grains: Dual Action of Lactiplantibacillus plantarum LTJ1/LTJ48 in Uric Acid Reduction and Gut Microbiota Restoration for Hyperuricemia Therapy in Mice.Nutrients. 2025 Jun 24;17(13):2097. doi: 10.3390/nu17132097. Nutrients. 2025. PMID: 40647202 Free PMC article.
-
Case report: Late middle-aged features of FAM111A variant, Kenny-Caffey syndrome type 2-suggestive symptoms during a long follow-up.Front Endocrinol (Lausanne). 2023 Jan 4;13:1073173. doi: 10.3389/fendo.2022.1073173. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36686468 Free PMC article. Review.
-
Hyperuricaemia and gout in the Pacific.Nat Rev Rheumatol. 2025 Apr;21(4):197-210. doi: 10.1038/s41584-025-01228-7. Epub 2025 Mar 11. Nat Rev Rheumatol. 2025. PMID: 40069386 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical